NCT06319872View on ClinicalTrials.gov

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 19, 2025

Primary Completion Date

May 19, 2029

Study Completion Date

May 19, 2029

Conditions
Alcohol Use DisorderRetinal DystrophiesAge-Related Macular DegenerationRetinitis PigmentosaStargardt Disease
Interventions
DRUG

Oral disulfiram

250 mg/day

Trial Locations (1)

14642

RECRUITING

Flaum Eye Institute, University of Rochester Medical Center, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT06319872 - The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration | Biotech Hunter | Biotech Hunter